EU faces fresh shortfall of AstraZeneca vaccine supplies

China aims to vaccinate 70-80% of population by mid-2022
13 March 2021
Italian region suspends AstraZeneca jabs after death
14 March 2021

EU faces fresh shortfall of AstraZeneca vaccine supplies

The European Union is facing further shortfalls in its coronavirus inoculation programme after Anglo/Swedish pharmaceutical giant AstraZeneca said production problems and export restrictions would reduce planned deliveries of its vaccine.

Comments are closed.